Facilitating the Use of COBRA Combination Therapy in Early Rheumatoid Arthritis: A Pilot Implementation Study

REFERENCES

1. 1.↵
   1. Boers M,
   2. Verhoeven AC,
   3. Markusse HM,
   4. et al

   . Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309–18.

   OpenUrlCrossRefPubMed
2. 2.
   1. Dougados M,
   2. Combe B,
   3. Cantagrel A,
   4. et al

   . Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 1999;58:220–5.

   OpenUrlAbstract/FREE Full Text
3. 3.
   1. Mottonen T,
   2. Hannonen P,
   3. Leirisalo-Repo M,
   4. et al

   . Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568–73.

   OpenUrlCrossRefPubMed
4. 4.
   1. O’Dell JR,
   2. Haire CE,
   3. Erikson N,
   4. et al

   . Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287–91.

   OpenUrlCrossRefPubMed
5. 5.
   1. Capell HA,
   2. Madhok R,
   3. Porter DR,
   4. et al

   . Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study. Ann Rheum Dis 2007;66:235–41.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Lehman AJ,
   2. Esdaile JM,
   3. Klinkhoff AV,
   4. Grant E,
   5. Fitzgerald A,
   6. Canvin J

   . A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis Rheum 2005;52:1360–70.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Landewe RB,
   2. Boers M,
   3. Verhoeven AC,
   4. et al

   . COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347–56.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Goekoop-Ruiterman YP,
   2. De Vries-Bouwstra JK,
   3. Allaart CF,
   4. et al

   . Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007;146:406–15.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Korthals-de Bos IBC,
   2. van Tulder MW,
   3. Boers M,
   4. et al

   . Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone. J Rheumatol 2004;3:1709–16.

   OpenUrl
10. 10.↵
    1. Verhoeven AC,
    2. Bibo JC,
    3. Boers M,
    4. Engel GL,
    5. van der Linden S

    . Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone. COBRA Trial Group. Combinatietherapie Bij Reumatoide Artritis. Br J Rheumatol 1998;37:1102–9.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Grimshaw JM,
    2. Shirran L,
    3. Thomas R,
    4. et al

    . Changing provider behavior: an overview of systematic reviews of interventions. Med Care 2001;39 Suppl:II2–45.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Grol R

    . Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001;286:2578–85.

    OpenUrlCrossRefPubMed
13. 13.↵
    COBRA therapy.nl. Amsterdam: VU University Medical Center and the Jan van Breemen Institute; 2008. [Internet. Accessed March 6, 2009] Available from: http://www.cobratherapy.nl
14. 14.↵
    1. van Tuyl LH,
    2. Plass AM,
    3. Lems WF,
    4. Voskuyl AE,
    5. Dijkmans BA,
    6. Boers M

    . Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? Ann Rheum Dis 2007;66:974–6.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. van Tuyl LHD,
    2. Plass AMC,
    3. Lems WF,
    4. et al

    . Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology 2008;47:1571–6. Epub 2008 Aug 18.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Ajzen I

    . Attitudes, personality and behaviour. London: Open University Press; 1988.
17. 17.↵
    1. Grol R,
    2. Dalhuijsen J,
    3. Thomas S,
    4. Veld C,
    5. Rutten G,
    6. Mokkink H

    . Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998;317:858–61.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Rogers E

    . Diffusion of innovations. New York: Free Press; 1983.
19. 19.↵
    1. Haas JS,
    2. Phillips KA,
    3. Gerstenberger EP,
    4. Seger AC

    . Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997–2000. Ann Intern Med 2005;142:891–7.

    OpenUrlCrossRefPubMed